1. Home
  2. TFSL vs ARQT Comparison

TFSL vs ARQT Comparison

Compare TFSL & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFS Financial Corporation

TFSL

TFS Financial Corporation

HOLD

Current Price

$14.71

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$23.11

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFSL
ARQT
Founded
1938
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.3B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
TFSL
ARQT
Price
$14.71
$23.11
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$34.00
AVG Volume (30 Days)
618.5K
973.7K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
7.67%
N/A
EPS Growth
14.29
88.79
EPS
0.08
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$9.16
$34.85
Revenue Next Year
$5.22
$29.39
P/E Ratio
$184.19
N/A
Revenue Growth
N/A
91.34
52 Week Low
$12.54
$12.42
52 Week High
$15.42
$31.77

Technical Indicators

Market Signals
Indicator
TFSL
ARQT
Relative Strength Index (RSI) 57.02 45.73
Support Level $13.16 $22.56
Resistance Level $15.06 $23.46
Average True Range (ATR) 0.28 0.89
MACD 0.01 -0.06
Stochastic Oscillator 54.33 25.17

Price Performance

Historical Comparison
TFSL
ARQT

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: